Women with obesity in cervical cancer screening. The double penalty: Underscreening and income inequalities.


Journal

Obesity research & clinical practice
ISSN: 1871-403X
Titre abrégé: Obes Res Clin Pract
Pays: Netherlands
ID NLM: 101303911

Informations de publication

Date de publication:
Historique:
received: 30 11 2020
accepted: 03 03 2021
pubmed: 28 3 2021
medline: 28 9 2021
entrez: 27 3 2021
Statut: ppublish

Résumé

The regular performance of Pap tests reduces the mortality of cervical cancer. Obesity is associated with low Pap test rates. We analyze the combined role of obesity and low income. We calculated a Slope Index of Inequality. Among the 28,905 women included, 23.1% were underscreened. The rate of underscreening increased with BMI. The income gradient increased significantly from 0.17 among normal-weight women to 0.19 in overweight and 0.23 in obese women (p = 0.047). Women who are obese are subject to a double penalty in cervical cancer screening: they are underscreened and subject to a more unfavorable economic gradient than normalweight women.

Identifiants

pubmed: 33771444
pii: S1871-403X(21)00045-4
doi: 10.1016/j.orcp.2021.03.003
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

212-215

Informations de copyright

Copyright © 2021 Asia Oceania Association for the Study of Obesity. Published by Elsevier Ltd. All rights reserved.

Auteurs

Jeanne Sassenou (J)

CESP, Inserm U1018, Université Paris-Saclay, université Paris-Sud, UVSQ, Villejuif, France. Electronic address: Jeanne.sassenou@universite-paris-saclay.fr.

Virginie Ringa (V)

CESP, Inserm U1018, Université Paris-Saclay, université Paris-Sud, UVSQ, Villejuif, France.

Marie Zins (M)

Inserm, Population-based Epidemiologic Cohorts Units, UMS 011, Villejuif, France.

Anna Ozguler (A)

Inserm, Population-based Epidemiologic Cohorts Units, UMS 011, Villejuif, France.

Sylvain Paquet (S)

CESP, Inserm U1018, Université Paris-Saclay, université Paris-Sud, UVSQ, Villejuif, France.

Henri Panjo (H)

CESP, Inserm U1018, Université Paris-Saclay, université Paris-Sud, UVSQ, Villejuif, France.

Jeanna-Eve Franck (JE)

RIS, Inserm/EHESS/CNRS, Aubervilliers, France.

Gwenn Menvielle (G)

Sorbonne Université, Inserm, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.

Laurent Rigal (L)

CESP, Inserm U1018, Université Paris-Saclay, université Paris-Sud, UVSQ, Villejuif, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH